A monumental moment in technology and medicine unfolded as Neuralink, the brain-chip startup, announced the successful implantation of its device in a human patient. The patient, who underwent the procedure on Sunday, is reportedly in good health, according to the company’s high-profile founder, Elon Musk.
Elon Musk revealed the news to Social Media earlier today
This leap forward isn’t just a testament to Neuralink’s ambition but marks a significant milestone in the field of brain-computer interfaces (BCIs). The U.S. Food and Drug Administration’s nod last year for human trials set the stage for this momentous occasion. The primary objective of these trials is audacious yet inspiring: to enable paralysis patients to control digital interfaces, such as computer cursors or keyboards, using only their thoughts.
The procedure, executed with precision by a surgical robot, involves placing an implant in the brain region that governs movement intention. The implant’s ultra-fine threads are designed to pick up neural signals, transforming thought into action in the digital realm. The company named its first product “Telepathy,” a fitting moniker for a technology that seems straight out of science fiction.
Despite the optimism surrounding this development, it’s important to recognize the scrutiny Neuralink has faced. Concerns have been raised about the safety protocols employed by the company, especially in light of a fine imposed by the U.S. Department of Transportation for mishandling hazardous materials. Moreover, a group of lawmakers has urged the U.S. Securities and Exchange Commission to investigate potential misrepresentations by Musk regarding the safety of Neuralink’s technology, following reports of adverse effects in animal trials.
RELATED:
- Better Late than Never, Neuralink is Now Accepting Applications for Human Trials
- Elon Musk Expects Neuralink’s First Human Trial to Kick Off This Year
- Big Discount: AOOSTAR R1 N100 NAS Mini PC Only For $159
- Best VR / AR Headsets of 2023 – Gizmochina
(Via)
